A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study assessed the relative bioavailability of 80 mg Atorvastatin Calcium Tablets
(containing atorvastatin calcium equivalent to 80 mg atorvastatin) manufactured by OHM
Laboratories, Inc., USA (A subsidiary of Ranbaxy Pharmaceuticals., USA) compared to that of
80 mg LIPITOR® Tablets (containing atorvastatin calcium equivalent to 80 mg atorvastatin)
distributed by Parke Davis, Division of Pfizer Inc., USA following a single oral dose (1 x 80
mg tablet) in healthy adult subjects when administered under fasting conditions.